Sensus Healthcare
SRTS
18 hedge funds and large institutions have $5.07M invested in Sensus Healthcare in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
59% more capital invested
Capital invested by funds: $3.19M → $5.07M (+$1.87M)
0.27% more ownership
Funds ownership: 7.69% → 7.96% (+0.27%)
18% less funds holding
Funds holding: 22 → 18 (-4)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$263K |
| 2 |
Renaissance Technologies
New York
|
+$17.7K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$12.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.49K |
| 5 |
BlackRock
New York
|
+$8.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$106K |
| 2 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$25.9K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$25K |
| 4 |
GBA
Garrison Bradford & Associates
New York
|
-$9.15K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4K |
SRTS Hedge Fund Activity: Q4 2020 in Review
18 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Sensus Healthcare (SRTS) for Q4 2020, worth a combined $5.07M — up 59% from $3.19M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of SRTS and 0 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 7 added.
The largest buyer was Invenomic Capital Management, adding an estimated $263K. The largest seller was Perkins Capital Management, cutting an estimated $106K.
- 18 institutional investors held Sensus Healthcare (SRTS) as of Q4 2020, down from 22 in Q3 2020.
- Funds reported $5.07M of Sensus Healthcare stock for Q4 2020, up 59% quarter-over-quarter.
- 0 funds opened new Sensus Healthcare positions in Q4 2020 and 4 closed out, a net change of -4 holders.
- The largest Sensus Healthcare buyer in Q4 2020 was Invenomic Capital Management, an estimated $263K added.
- The largest Sensus Healthcare seller in Q4 2020 was Perkins Capital Management, an estimated $106K sold.
Based on aggregated 13F filings for Q4 2020.